Skip to Main Content

Author Details

Louise E Hogan
University of California San Francisco
2012
19
11
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
32780519Everolimus, an mTORC1/2 inhibitor, in ART-suppressed individuals who received solid organ transplantation: A prospective study.Am J Transplant2021
33536176Evaluating a New Class of AKT/mTOR Activators for HIV Latency Reversing Activity <i>Ex Vivo and In Vivo</i>.J Virol2021
32175087Cerebrospinal fluid soluble CD30 elevation despite suppressive antiretroviral therapy in individuals living with HIV-1.J Virus Erad2020
31139759CD32-RNA Co-localizes with HIV-RNA in CD3+ Cells Found within Gut Tissues from Viremic and ART-Suppressed Individuals.Pathog Immun2019
31640575Correction to: Rapid development of HIV elite control in a patient with acute infection.BMC Infect Dis2019
31533639Rapid development of HIV elite control in a patient with acute infection.BMC Infect Dis2019
29462571Elucidating the Burden of HIV in Tissues Using Multiplexed Immunofluorescence and In Situ Hybridization: Methods for the Single-Cell Phenotypic Characterization of Cells Harboring HIV In Situ.J Histochem Cytochem2018
29921650NK-cell activation is associated with increased HIV transcriptional activity following allogeneic hematopoietic cell transplantation.Blood Adv2018
30530753Transient loss of detectable HIV-1 RNA following brentuximab vedotin anti-CD30 therapy for Hodgkin lymphoma.Blood Adv2018
29470552Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30.PLoS Pathog2018
29746555Human Herpes Virus 8 in HIV-1 infected individuals receiving cancer chemotherapy and stem cell transplantation.PLoS One2018
28838149Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy.J Infect Dis2017
28432928A humanized mouse-based HIV-1 viral outgrowth assay with higher sensitivity than in vitro qVOA in detecting latently infected cells from individuals on ART with undetectable viral loads.Virology2017
29112956HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.PLoS Med2017
28529033High-throughput Characterization of HIV-1 Reservoir Reactivation Using a Single-Cell-in-Droplet PCR Assay.EBioMedicine2017
26908331Expression of the innate immune receptor LILRB5 on monocytes is associated with mycobacteria exposure.Sci Rep2016
25853653Cerebrospinal fluid cytokine profiles predict risk of early mortality and immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis.PLoS Pathog2015
24825871Very low levels of 25-hydroxyvitamin D are not associated with immunologic changes or clinical outcome in South African patients with HIV-associated cryptococcal meningitis.Clin Infect Dis2014
22485161Characterisation of bovine leukocyte Ig-like receptors.PLoS One2012
  • 1 - 19 of 19

Recommended Authors

National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2015
Number of shared co-authors 7
University of Wisconsin
Career Start Year 2010
Number of shared co-authors 0
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Career Start Year 2010
Number of shared co-authors 3
The Rockefeller University
Career Start Year 2010
Number of shared co-authors 2
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2006
Number of shared co-authors 6
National Institute of Molecular Genetics, "Fondazione Romeo ed Enrica Invernizzi"
Career Start Year 2005
Number of shared co-authors 1
University of California San Francisco
Career Start Year 2002
Number of shared co-authors 10
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2000
Number of shared co-authors 8
University of North Carolina at Chapel Hill
Career Start Year 2000
Number of shared co-authors 0
George Washington University
Career Start Year 2000
Number of shared co-authors 5
University of California San Francisco
Career Start Year 1999
Number of shared co-authors 3
Icahn School of Medicine at Mount Sinai
Career Start Year 1997
Number of shared co-authors 2
Ragon Institute of MGH
Career Start Year 1995
Number of shared co-authors 5
The University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Career Start Year 1993
Number of shared co-authors 13
Inc., Frederick National Laboratory for Cancer Research
Career Start Year 1993
Number of shared co-authors 4
Fred Hutchinson Cancer Center
Career Start Year 1991
Number of shared co-authors 9
University of Pennsylvania School of Medicine
Career Start Year 1988
Number of shared co-authors 3
IF School of Medicine, University of Pennsylvania
Career Start Year 1987
Number of shared co-authors 7
Ragon Institute of Mass General
Career Start Year 1987
Number of shared co-authors 11
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year 1987
Number of shared co-authors 5
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1985
Number of shared co-authors 6
University of Massachusetts Chan Medical School
Career Start Year 1985
Number of shared co-authors 2
Vanderbilt University Medical Center
Career Start Year 1983
Number of shared co-authors 0
Pathology Advanced Translational Research Unit, Emory University School of Medicine
Career Start Year 1981
Number of shared co-authors 12
Division of Clinical Research, National Institutes of Allergy and Infectious Diseases
Career Start Year 1981
Number of shared co-authors 7
Northwestern University Feinberg School of Medicine
Career Start Year 1979
Number of shared co-authors 13
IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol
Career Start Year 1979
Number of shared co-authors 5
Vir Biotechnology Inc.
Career Start Year 1977
Number of shared co-authors 4
Johns Hopkins Bloomberg School of Public Health
Career Start Year 1973
Number of shared co-authors 6
Wistar Institute
Career Start Year 1958
Number of shared co-authors 7

Collaborators

University of California san francisco
Co-authored papers 15
University of California san francisco
Co-authored papers 9
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 6
Vitalant Research Institute
Co-authored papers 4
Co-authored papers 2
Co-authored papers 2
University College London
Co-authored papers 1
Buck Institute for Research on Aging
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Vitalant Research Institute
Co-authored papers 1
Gladstone Institutes
Co-authored papers 1
Frederick National Laboratory
Co-authored papers 1
J. David Gladstone Institutesgrid.249878.8
Co-authored papers 1
Gladstone Institute of Virology, Gladstone Institutes
Co-authored papers 1
AMO Pharma Ltd.
Co-authored papers 1
University of California, USA Gladstone Institutes san francisco
Co-authored papers 1
Vaccine & Gene Therapy Institute, and Oregon National Primate Research Center
Co-authored papers 1
Gladstone Institutes
Co-authored papers 1
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 1
Vitalant Research Institute, USA University of California san francisco
Co-authored papers 1
Center for AIDS Research, University of California San Diego
Co-authored papers 1
Vaccine and Gene Therapy Institute and.
Co-authored papers 1
Institute for Translational HIV Research, University Hospital Essen
Co-authored papers 1
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Gladstone Institute of Virology
Co-authored papers 1
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 1
Gladstone Institute of Virology, USA University of California san francisco
Co-authored papers 1
Johns Hopkins School of Medicine, Johns Hopkins University
Co-authored papers 1